Healthcare provider profile · identity verified

Sarma Venkata Katrapati, M.D.

Internal Medicine · TOLEDO, OH · NPI 1467485227

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	732	198
Levothyroxine Sodium	Levothyroxine Sodium	546	135
Amlodipine Besylate	Amlodipine Besylate	542	137
Omeprazole	Omeprazole	475	107
Losartan Potassium	Losartan Potassium	366	92
Metformin Hcl	Metformin Hcl	331	81
Lisinopril	Lisinopril	330	73
Pantoprazole Sodium	Pantoprazole Sodium	325	84
Metoprolol Succinate	Metoprolol Succinate	294	81
Metoprolol Tartrate	Metoprolol Tartrate	262	58
Pravastatin Sodium	Pravastatin Sodium	224	52
Gabapentin	Gabapentin	220	48
Allopurinol	Allopurinol	217	50
Hydrochlorothiazide	Hydrochlorothiazide	209	56
Potassium Chloride	Potassium Chloride	190	42
Rosuvastatin Calcium	Rosuvastatin Calcium	185	46
Trazodone Hcl	Trazodone Hcl	183	41
Fluticasone Propionate	Fluticasone Propionate	180	76
Escitalopram Oxalate	Escitalopram Oxalate	173	44
Simvastatin	Simvastatin	170	43
Montelukast Sodium	Montelukast Sodium	158	43
Furosemide	Furosemide	150	46
Sertraline Hcl	Sertraline Hcl	146	27
Alprazolam	Alprazolam	141	21
Clopidogrel	Clopidogrel Bisulfate	141	28
Albuterol Sulfate Hfa	Albuterol Sulfate	138	54
Tamsulosin Hcl	Tamsulosin Hcl	136	34
Glimepiride	Glimepiride	135	35
Citalopram Hbr	Citalopram Hydrobromide	127	30
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	121	33
Bupropion Xl	Bupropion Hcl	117	22
Prednisone	Prednisone	113	84
Carvedilol	Carvedilol	101	28
Eliquis	Apixaban	101	23
Spironolactone	Spironolactone	88	26
Azithromycin	Azithromycin	83	68
Buspirone Hcl	Buspirone Hcl	81	23
Quetiapine Fumarate	Quetiapine Fumarate	81	14
Tizanidine Hcl	Tizanidine Hcl	81	24
Tramadol Hcl	Tramadol Hcl	78	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	77	18
Tradjenta	Linagliptin	76	11
Ozempic	Semaglutide	72	15
Januvia	Sitagliptin Phosphate	71	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	69	22
Meloxicam	Meloxicam	67	18
Duloxetine Hcl	Duloxetine Hcl	63	16
Fluoxetine Hcl	Fluoxetine Hcl	62	15
Synthroid	Levothyroxine Sodium	62	16
Ondansetron Hcl	Ondansetron Hcl	60	14
Triamcinolone Acetonide	Triamcinolone Acetonide	58	27
Zolpidem Tartrate	Zolpidem Tartrate	56	14
Famotidine	Famotidine	54	18
Mirtazapine	Mirtazapine	52	suppressed
Celecoxib	Celecoxib	51	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	51	12
Venlafaxine Hcl Er	Venlafaxine Hcl	50	13
Lorazepam	Lorazepam	49	12
Farxiga	Dapagliflozin Propanediol	47	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	47	14
Glipizide	Glipizide	46	15
Metformin Hcl Er	Metformin Hcl	46	12
Nifedipine Er	Nifedipine	45	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	suppressed
Jardiance	Empagliflozin	40	suppressed
Cephalexin	Cephalexin	37	28
Carisoprodol	Carisoprodol	35	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Atenolol	Atenolol	34	11
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Valsartan	Valsartan	34	11
Ventolin Hfa	Albuterol Sulfate	34	suppressed
Clonidine Hcl	Clonidine Hcl	33	suppressed
Donepezil Hcl	Donepezil Hcl	33	suppressed
Lovastatin	Lovastatin	33	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	31	suppressed
Propranolol Hcl	Propranolol Hcl	31	suppressed
Pregabalin	Pregabalin	29	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	28	suppressed
Ezetimibe	Ezetimibe	28	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	suppressed
Ibuprofen	Ibuprofen	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Valacyclovir	Valacyclovir Hcl	27	suppressed
Irbesartan	Irbesartan	26	suppressed
Rivastigmine	Rivastigmine	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Colchicine	Colchicine	25	suppressed
Myrbetriq	Mirabegron	25	suppressed
Cefuroxime	Cefuroxime Axetil	24	23
Finasteride	Finasteride	24	suppressed
Meclizine Hcl	Meclizine Hcl	24	18
Terazosin Hcl	Terazosin Hcl	24	suppressed
Vraylar	Cariprazine Hcl	24	suppressed
Fenofibrate	Fenofibrate	23	suppressed
Mounjaro	Tirzepatide	23	suppressed
Ramipril	Ramipril	23	suppressed
Amiloride-Hydrochlorothiazide	Amiloride/Hydrochlorothiazide	22	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	22	suppressed
Topiramate	Topiramate	22	suppressed
Verapamil Er	Verapamil Hcl	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Warfarin Sodium	Warfarin Sodium	21	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Solifenacin Succinate	Solifenacin Succinate	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Benazepril Hcl	Benazepril Hcl	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Naproxen	Naproxen	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Acarbose	Acarbose	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	18	suppressed
Lansoprazole	Lansoprazole	18	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	17	suppressed
Dulera	Mometasone/Formoterol	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Ketoconazole	Ketoconazole	17	suppressed
Klor-Con M20	Potassium Chloride	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Promethazine Hcl	Promethazine Hcl	16	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Digoxin	Digoxin	15	suppressed
Estradiol	Estradiol	15	suppressed
Levetiracetam	Levetiracetam	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	15	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Cilostazol	Cilostazol	14	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Nystatin	Nystatin	14	11
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	14	suppressed
Aimovig Autoinjector	Erenumab-Aooe	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Klor-Con M10	Potassium Chloride	13	suppressed
Linzess	Linaclotide	13	suppressed
Nateglinide	Nateglinide	13	suppressed
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	13	suppressed
Budesonide	Budesonide	12	suppressed
Levemir Flexpen	Insulin Detemir	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Tresiba Flextouch U-100	Insulin Degludec	12	suppressed
Ultra-Fine Original Pen Needle	Pen Needle, Diabetic	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error